Home > Result Summaries: Compounds > argatroban Result Summaries: argatroban GSKStudy ID Phase Title Summary (Download) 105043/011 Phase 2 An Open-label, Multicenter, Adaptive Design, Pilot Trial to Examine the Safety and Effectiveness of Argatroban in Combination with Abciximab, a Platelet GP IIb/IIIa Receptor Antagonist in Patients Undergoing Non-urgent Percutaneous Coronary Intervention (6 citation(s)) 105043/011_1 Phase 2 An Open-label, Multicenter, Adaptive Design, Pilot Trial to Examine the Safety and Effectiveness of Argatroban in Combination with Abciximab, a Platelet GP IIb/IIIa Receptor Antagonist in Patients Undergoing Non-urgent Percutaneous Coronary Intervention (Part 2) (6 citation(s)) 105043/013 Phase 2 An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (0 citation(s)) ARG-402 Phase 2 Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis (1 citation(s))
